Pharmaceutical Manufacturer

Kimberly-Clark buys Tylenol in US$48.7 billion consumer brands deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about US$48.7 billion, creating a massive consumer health goods company.
Pfizer amps up push into obesity treatments with $4.9B deal for Metsera
The COVID-19 vaccine and treatment maker said Monday that it will pay $47.50 in cash for each share of development-stage drugmaker Metsera. That represents a premium of more than 42% to Metsera’s closing price last Friday.

Suspicions of illegal advertising: Employee pharmacist finally acquitted

Pharmacist accused of promoting two ophthalmic solutions to doctors for which he was the sole shareholder and distributor, while an employee of the only pharmacy that prepared these solutions.
Despite PPNs, Canada is still ‘far from U.S.-style coverage’

A new study from C.D. Howe found that there’s little evidence of widespread harm if PPNs are introduced into the Canadian healthcare system.
B.C. health minister apologizes to family of 10-year-old girl with rare disease

No cure exists for the rare neurodegenerative disorder that causes seizures, blindness and declining motor functions.
Trump’s 200% drug tariffs: a prescription for disaster

US president Trump's recently announced 200% tariffs on pharmaceuticals could have far-reaching implications—and perhaps even a silver lining.
New guidelines from PMPRB on monitoring and reviewing drug prices

These new rules will come into effect on January 1, 2026.
Did Novo Nordisk lose their Ozempic patent in Canada because they didn't pay a $450 fee?

Novo Nordisk's Canadian patent for Ozempic expired after it didn't pay a $450 maintenance fee. With generic semaglutide on the horizon, was this a mistake that could cost the company billions?
Three new generics pharmacists and physicians should know about

Get the info you need on these new generics, part of our drug news roundup for April.
McMaster University researchers recruiting for clinical trials on new Canadian-made inhaled COVID-19 vaccine

Researchers say their inhaled vaccine could potentially offer even better protection than the currently available needle-based vaccines.

Kimberly-Clark buys Tylenol in US$48.7 billion consumer brands deal

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

Suspicions of illegal advertising: Employee pharmacist finally acquitted

Despite PPNs, Canada is still ‘far from U.S.-style coverage’

B.C. health minister apologizes to family of 10-year-old girl with rare disease

Trump’s 200% drug tariffs: a prescription for disaster

New guidelines from PMPRB on monitoring and reviewing drug prices

Did Novo Nordisk lose their Ozempic patent in Canada because they didn't pay a $450 fee?

Three new generics pharmacists and physicians should know about

McMaster University researchers recruiting for clinical trials on new Canadian-made inhaled COVID-19 vaccine